Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director of the Institute of Health and Wellbeing at the University of Suffolk, UK. He is a Chartered Health Psychologist and a Chartered Scientist. He also trained in analytical biochemistry, this aspect reflecting the psychobiological focus of much of his research within mental health. He has published or has in press well over 300 research papers and book chapters. He is a keen book author and editor having written and/or edited more than 50 books. These outputs include the prophetic insight into the treatment of neurological disease, Handbook of Behavior, Food and Nutrition (2011), Nanomedicine and the Nervous System (2012), Oxidative Stress and Dietary Antioxidants in Neurological Disease (2020), Zika Virus Impact, Diagnosis, Control and Models (2021), Factors Affecting Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021), Diagnosis and Treatment of Spinal Cord Injury (2022), The Neurobiology, Physiology, and Psychology of Pain (2022) and The Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor Martin is particularly interested in all aspects of the relationship between underlying physiological substrates and behavior, particularly in how these relationships manifest in both acute and chronic psychiatric disorder. He has published original research germane to significant mental health disorders including the areas of schizophrenia, anxiety, depression, self-esteem, alcohol and drug dependency, high secure forensic mental health and personality disorder. He has a keen interest in the impact of postviral illness and is actively involved in clinical research post-Covid pandemic and in particular, the impact of Long Covid on psychological, neurological, physiological and social functioning. He is involved in collaborative International research with many European and Non-European countries. Dr. Patel is a Reader at the University of Westminster. After completing his PhD at King’s College London, he continued his research experience by undertaking his post-doctoral studies in the laboratory of Professor Cunningham in the Department of Biochemistry at the Wake Forest University School of Medicine, (Winston-Salem, NC, USA). This extensive project involved investigating mechanisms of hepatic mitochondrial ribosome dysfunction in alcoholic liver disease (ALD) using biophysical and proteomic techniques. These studies have led to new avenues in determining the pathology of ALD. His teaching areas at both post-graduate and undergraduate levels include clinical biochemistry, investigative pathology and laboratory investigation. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

• Section 1: Alzheimer’s Disease and Dementias1. Caenorhabditis elegans model of Alzheimer's disease: applications to drug screening2. APPswe/ PS1dE9 mouse model of Alzheimer’s disease: [18F]-florbetaben pet/ct imaging and beyond3. Rat model of Alzheimer: applications to brain a-beta plaque accumulationSection 2: Amyotrophic Lateral Sclerosis4. Murine modelling of familial amyotrophic lateral sclerosis, SOD1G86R: applications to ambroxol HCl5. Rat Model of amyotrophic lateral sclerosis: SOD1G93A applications to mitochondria6. Zebrafish model of amyotrophic lateral sclerosis: applications to oxidative stress studies in spinal motor neuronsSection 3: Brain Injury7. Murine models of traumatic brain injury and knock outs: investigations on hypocretin8. Rat model of cortical impact traumatic brain injury: applications to studying neural stem cell grafts9. Porcine modelling of traumatic brain injury: investigating agents such as valproic acid and beyondSection 4: Cerebral Palsy10. Animal models of cerebral palsy: a new narrative11. Rat model of cerebral palsy: applications to studying motor phenotype12. Rabbit cerebral palsy modelling: applications to studying spinal hyper-excitabilitySection 5: Epilepsy13. Murine modelling of epilepsy: applications to microRNA and hippocampus14. Kainic acid-induced rat model of status epilepticus: A gamma-aminobutyric acid levels15. Rats modelling of temporal lobe epilepsy: linking in cognitionSection 6: Headaches and Migraines16. A new narrative of genetic mouse models of migraine: features and applications17. Rat model of headache with nitroglycerin: impact of auricular electrical stimulation18. Nitroglycerin-induced migraine in mice: Nociceptin Opioid (NOP) receptors and beyondSection 7: Meningitis Rabbit tuberculous meningitis models: applications to neurosciences19. Experimental pneumococcal meningitis: hippocampal DNA methylation20. Pneumococcal meningitis modelling in miceSection 8: Multiple Sclerosis Biological models in multiple sclerosis: a new overview and narrative21. The mouse model of multiple sclerosis : use of Artemisia dracunculus L.22. Comparing models of multiple sclerosis: applications to biomarkersSection 9: Neuroinflammation Modelling neuroinflammation: CXCR2 signalling and myelin repair23. Lipopolysaccharide- model of neuroinflammation: astrogliosis, microglial activation and beyond24. Rat model of neuroinflammation: positron emission tomography (PET) tracer for imaging of P2X7 receptorsSection 10: Neurotoxins Animal models in the neurotoxicology of the neurotoxin 2,4-D25. Toluene as a model neurotoxin in mouse models 1-11-201926. Rat model of alcohol-related brain damage: application to thiamine deficiency and cytokinesSection 11: Parkinson’s Disease 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine( MPTP)-induced mouse model of Parkinson's disease: impact of Valeriana officinalis27. alpha-synuclein BAC transgenic mice model of Parkinson's disease: the sublaterodorsal tegmental nucleus and beyond28. Rat model of parkinsonism: the nigro-vagal pathwaySection 12: Peripheral Neuropathy Non-mammalian animal models of peripheral neuropathy29. Mouse models of peripheral neuropathy: neurogenic molecule NSI-18930. Rat model of cisplatin-induced peripheral neuropathy: features and applicationsSection 13: Prenatal Related Injury Porcine model of intrauterine growth restriction: Applications to the study of the hippocampus31. Ethanol as a neurotoxin in model primates for in vitro exposure: brain development and beyond32. Prenatal malnutrition: linking in oxidative stressSection 14: Stroke Mouse model of ischemic stroke: PET tracers33. Canine model of stroke: optimizing complex multimodal treatment34. Porcine Ischemic Stroke and applications to neural stem cells

Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director of the Institute of Health and Wellbeing at the University of Suffolk, UK. He is a Chartered Health Psychologist and a Chartered Scientist. He also trained in analytical biochemistry, this aspect reflecting the psychobiological focus of much of his research within mental health. He has published or has in press well over 300 research papers and book chapters. He is a keen book author and editor having written and/or edited more than 50 books. These outputs include the prophetic insight into the treatment of neurological disease, Handbook of Behavior, Food and Nutrition (2011), Nanomedicine and the Nervous System (2012), Oxidative Stress and Dietary Antioxidants in Neurological Disease (2020), Zika Virus Impact, Diagnosis, Control and Models (2021), Factors Affecting Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021), Diagnosis and Treatment of Spinal Cord Injury (2022), The Neurobiology, Physiology, and Psychology of Pain (2022) and The Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor Martin is particularly interested in all aspects of the relationship between underlying physiological substrates and behavior, particularly in how these relationships manifest in both acute and chronic psychiatric disorder. He has published original research germane to significant mental health disorders including the areas of schizophrenia, anxiety, depression, self-esteem, alcohol and drug dependency, high secure forensic mental health and personality disorder. He has a keen interest in the impact of postviral illness and is actively involved in clinical research post-Covid pandemic and in particular, the impact of Long Covid on psychological, neurological, physiological and social functioning. He is involved in collaborative International research with many European and Non-European countries. Dr. Patel is a Reader at the University of Westminster. After completing his PhD at King’s College London, he continued his research experience by undertaking his post-doctoral studies in the laboratory of Professor Cunningham in the Department of Biochemistry at the Wake Forest University School of Medicine, (Winston-Salem, NC, USA). This extensive project involved investigating mechanisms of hepatic mitochondrial ribosome dysfunction in alcoholic liver disease (ALD) using biophysical and proteomic techniques. These studies have led to new avenues in determining the pathology of ALD. His teaching areas at both post-graduate and undergraduate levels include clinical biochemistry, investigative pathology and laboratory investigation. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

• Section 1: Alzheimer’s Disease and Dementias1. Caenorhabditis elegans model of Alzheimer's disease: applications to drug screening2. APPswe/ PS1dE9 mouse model of Alzheimer’s disease: [18F]-florbetaben pet/ct imaging and beyond3. Rat model of Alzheimer: applications to brain a-beta plaque accumulationSection 2: Amyotrophic Lateral Sclerosis4. Murine modelling of familial amyotrophic lateral sclerosis, SOD1G86R: applications to ambroxol HCl5. Rat Model of amyotrophic lateral sclerosis: SOD1G93A applications to mitochondria6. Zebrafish model of amyotrophic lateral sclerosis: applications to oxidative stress studies in spinal motor neuronsSection 3: Brain Injury7. Murine models of traumatic brain injury and knock outs: investigations on hypocretin8. Rat model of cortical impact traumatic brain injury: applications to studying neural stem cell grafts9. Porcine modelling of traumatic brain injury: investigating agents such as valproic acid and beyondSection 4: Cerebral Palsy10. Animal models of cerebral palsy: a new narrative11. Rat model of cerebral palsy: applications to studying motor phenotype12. Rabbit cerebral palsy modelling: applications to studying spinal hyper-excitabilitySection 5: Epilepsy13. Murine modelling of epilepsy: applications to microRNA and hippocampus14. Kainic acid-induced rat model of status epilepticus: A gamma-aminobutyric acid levels15. Rats modelling of temporal lobe epilepsy: linking in cognitionSection 6: Headaches and Migraines16. A new narrative of genetic mouse models of migraine: features and applications17. Rat model of headache with nitroglycerin: impact of auricular electrical stimulation18. Nitroglycerin-induced migraine in mice: Nociceptin Opioid (NOP) receptors and beyondSection 7: Meningitis Rabbit tuberculous meningitis models: applications to neurosciences19. Experimental pneumococcal meningitis: hippocampal DNA methylation20. Pneumococcal meningitis modelling in miceSection 8: Multiple Sclerosis Biological models in multiple sclerosis: a new overview and narrative21. The mouse model of multiple sclerosis : use of Artemisia dracunculus L.22. Comparing models of multiple sclerosis: applications to biomarkersSection 9: Neuroinflammation Modelling neuroinflammation: CXCR2 signalling and myelin repair23. Lipopolysaccharide- model of neuroinflammation: astrogliosis, microglial activation and beyond24. Rat model of neuroinflammation: positron emission tomography (PET) tracer for imaging of P2X7 receptorsSection 10: Neurotoxins Animal models in the neurotoxicology of the neurotoxin 2,4-D25. Toluene as a model neurotoxin in mouse models 1-11-201926. Rat model of alcohol-related brain damage: application to thiamine deficiency and cytokinesSection 11: Parkinson’s Disease 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine( MPTP)-induced mouse model of Parkinson's disease: impact of Valeriana officinalis27. alpha-synuclein BAC transgenic mice model of Parkinson's disease: the sublaterodorsal tegmental nucleus and beyond28. Rat model of parkinsonism: the nigro-vagal pathwaySection 12: Peripheral Neuropathy Non-mammalian animal models of peripheral neuropathy29. Mouse models of peripheral neuropathy: neurogenic molecule NSI-18930. Rat model of cisplatin-induced peripheral neuropathy: features and applicationsSection 13: Prenatal Related Injury Porcine model of intrauterine growth restriction: Applications to the study of the hippocampus31. Ethanol as a neurotoxin in model primates for in vitro exposure: brain development and beyond32. Prenatal malnutrition: linking in oxidative stressSection 14: Stroke Mouse model of ischemic stroke: PET tracers33. Canine model of stroke: optimizing complex multimodal treatment34. Porcine Ischemic Stroke and applications to neural stem cells